Skyscape Web Viewer : EBMG: Pulmonary Diseases : Mesh Index

View All
Urinary Incontinence
Urinary protein ACE Inhibitors and Angiotensin Receptor Blockers for Progression of Non-Diabetic Renal Disease Antiproteinuric and Renoprotective Effects of ACE Inhibitors and Angiotensin II Receptor Blockers Corticosteroids in Iga Nephropathy
Urinary Retention
Urinary Sphincter, Artificial
Urinary Tract Infections
Urinary Tract
Urination Alarm Interventions for Nocturnal Enuresis in Children Removal of Short-Term Indwelling Urethral Catheters
Albuterol Bronchodilators for Bronchiolitis Chronic Obstructive Pulmonary Disease (COPD) Inhaled Beta2-Agonists for Chronic Cough in Children Long-Acting Beta2-Agonists in Addition to Inhaled Corticosteroids in Chronic Asthma Long-Term Management of Asthma Mometasone for Chronic Asthma Treatment of Acute Exacerbation of Asthma
Alcohol dependencealcohol-Related Disorders
Alcohol Dependence
Alcohol Deterrents
Alcohol Drinking Amount of Feedback of Prenatal Ultrasound for Reducing Maternal Anxiety and Improving Maternal Health Behaviour in Pregnancy. Brief Alcohol Interventions in Primary Care Populations Brief Interventions for Heavy Alcohol Users Injuries in Problem Drinkers Nalmefene for Alcohol Dependence Naltrexone for Alcohol Dependence Opportunistic Screening for Alcohol Use Disorders in Primary Care Social Norms Interventions to Reduce Alcohol Misuse in University or College Students The Alcohol Use Disorders Identification Test for Consumption (Audit-C) for Predicting Hazardous Drinking Therapeutic Communities for Substance Related Disorder
Alcoholic hepatitis Alcohol-related diseases Cirrhosis of the Liver - Related Resources Cochrane review Evidence summary Gastroenterology Glucocorticoids in Alcoholic Hepatitis Internal medicine Milk Thistle for Alcoholic and /or Hepatitis B or C Virus Liver Diseases Pentoxifylline for Alcoholic Hepatitis Substance-related disorders Systematic review
Alcoholics anonymous Addiction medicine Alcoholics Anonymous and other 12-Step Programmes for Alcohol Dependence Alcohol-related diseases Cochrane review Evidence summary Substance-related disorders Systematic review
Alcohol-Induced Disorders Opportunistic Screening for Alcohol Use Disorders in Primary Care The Alcohol Use Disorders Identification Test for Consumption (Audit-C) for Predicting Hazardous Drinking Thiamine for Wernicke-Korsakoff Syndrome in Alcohol Abuse
Alcohol-Induced Disorders, Nervous System
Alcoholism
Alcohol-related diseases
Alcohol-Related Disorders Baclofen for Alcohol Use Disorder Baclofen for Alcohol Withdrawal Home Visits after Birth for Women with an Alcohol or Drug Problem Injuries in Problem Drinkers Therapeutic Communities for Substance Related Disorder
Alcohol Use Disorders Identification Test Alcohol-related diseases Brief Interventions for Heavy Use of Alcohol - Related Resources Evidence summary Female Internal medicine Opportunistic Screening for Alcohol Use Disorders in Primary Care Public health Systematic review The Alcohol Use Disorders Identification Test for Consumption (Audit-C) for Predicting Hazardous Drinking
Alcohol Withdrawal Delirium
Alcohol Withdrawal Seizures Anticonvulsants for Alcohol Withdrawal Benzodiazepines for Alcohol Withdrawal
Alcohol withdrawal syndrome Anticonvulsants for Alcohol Withdrawal Benzodiazepines for Alcohol Withdrawal Cochrane review Evidence summary Female Magnesium and Alcohol Withdrawal Syndrome Systematic review
Alcohol withdrawal
Aldehyde Reductase
Aldosterone Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease Aldosterone Receptor Antagonists Spironolactone and Eplerenone for Congestive Heart Failure Cardiology Cochrane review Combining ACE Inhibitors and Angiotensin Receptor Blockers in Renal Disease Dietary Sodium Restriction, Blood Pressure and Cardiovascular Morbidity Drugs for Chronic Heart Failure with Preserved Ejection Fraction Evidence summary Female Internal medicine Nephrology Pharmacology Systematic review
Alendronate Alendronate for the Primary and Secondary Prevention of Osteoporotic Fractures in Postmenopausal Women Bisphosphonates in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis Bisphosphonate Therapy for Children and Adolescents with Secondary Osteoporosis Cochrane review Effects of Continuing or Stopping Alendronate after 5 Years of Treatment Endocrinology Evidence summary Female Internal medicine Interventions for Decreased Bone Mineral Density Associated with HIV Infection Osteoporosis - Related Resources Systematic review
Alfa-adrenergic antagonist
Algorithms Interventions Based on Sputum Eosinophils for Asthma Reliability and Effectiveness of Real-Time Ultrasonic Bladder Volume Estimation
Alkalies